683 Capital Management’s Zura Bio ZURA Stock Holding History

683 Capital Management’s Portfolio ZURA Stock Details ZURA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-110,000	Closed	-$655K	–	244
2026 Q1	$655K	Sell	110,000 -149,165	-58%	-$901K	0.03%	165
2025 Q4	$1.36M	Buy	+259,165	New	+$1.02M	0.06%	120

Other funds holding ZURA

SCM

Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return

VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return

MPM BioImpact Boston, Massachusetts $1.64B AUM 245.64% 1-Year Est. Return

GPP

Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

683 Capital Management's ZURA Position: Q2 2026 in Review

683 Capital Management sold out of Zura Bio (ZURA) in Q2 2026, closing a stake of 110,000 shares — an estimated $655K sold.

683 Capital Management first reported a position in ZURA in Q4 2025 and held it in 2 quarters. The position peaked at $1.36M in Q4 2025. 95 funds tracked by Wall St. Rank hold ZURA as of Q2 2026.

683 Capital Management reported no remaining Zura Bio position as of Q2 2026 after selling out during the quarter.
683 Capital Management sold 110,000 Zura Bio shares in Q2 2026, an estimated $655K.
683 Capital Management first reported a position in Zura Bio in Q4 2025 and held it in 2 quarters.
683 Capital Management's Zura Bio position peaked at $1.36M in Q4 2025.
95 funds tracked by Wall St. Rank held Zura Bio as of Q2 2026.

Based on 683 Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.